Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease - Abstract

Published on 09 August 2012

PURPOSE: To determine gastrointestinal (GI) toxicity after ¹²⁵I prostate brachytherapy in patients with inflammatory bowel disease (IBD).

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.

Tags:

Prostate Cancer

<a href='http://ads.urotoday.com/www/delivery/ck.php?n=a1716eb4&cb={random}' target='_blank'><img src='http://ads.urotoday.com/www/delivery/avw.php?zoneid=118&cb={random}&n=a1716eb4' border='0' alt='' /></a>

caselectures

Copyright © 2002 - 2013 Digital Science Press, Inc.

website design firm : Web-JIVE LLC